Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines. $CDAK
Cambridge, MA
Joined May 2016
- Tweets156
- Following11
- Followers307
- Likes11
Codiak BioSciences retweeted
📢We're partnering with @CodiakBio to advance vaccine candidates from its pan Betacoronavirus programme through preclinical studies.
CEPI will provide $2.5m seed funding to support the work ⏬
cepi.net/news_cepi/cepi-part…
Codiak BioSciences retweeted
We have acquired an exosome manufacturing site from @codiakbio, in Lexington, Massachusetts (US), and established a long-term strategic collaboration focused on jointly developing our exosome manufacturing and characterization technologies. pharma.lonza.com/technologie…
Codiak BioSciences retweeted
Su Chul Jang et al engineered an extracellular vesicle loaded with a potent cyclic dinucleotide agoist of the STING pathway. ExoSTING was retained better in tumors and produced lower levels of systemic inflammatory cytokine production. @codiakbio nature.com/articles/s42003-0…
Codiak BioSciences retweeted
@ka_blankenship will also be keeping a running column with items on news from #AACR21 this weekend --
AACR roundup: Arcus rolls out PhI/II data on adenosine blocker for CRC; Codiak's engineered exosome for IL-12 shows early promise
endpts.com/aacr-roundup-arcu…
Codiak BioSciences retweeted
Today, the team at @CodiakBio rang @Nasdaq's closing bell in honor of #CodiakIPO! 🔔🎉
Congratulations to all involved. #NasdaqListed $CDAK
Codiak BioSciences retweeted
Please join us in welcoming @CodiakBio to the @Nasdaq family! 👏
Codiak BioSciences, Inc. is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics. #NasdaqListed $CDAK
